IL18 and neoplasm: These findings suggest that the combined effects of IL-18 and IL-21 may have created a cytokine milieu capable of reprogramming CD8+ T cells toward an NKT-like phenotype, especially in the context of tumor antigen exposure and APC-mediated TCR engagement.